FDA gives thumbs-up to Toshiba 1.5T MRI

The FDA has cleared Toshiba America Medical Systems' Vantage Titan 1.5T series, which features 8-, 16- and 32-channel MR systems.

The series offers an upgrade path from the 8-channel to the 32-channel system. In addition to these upgrades, the entire Titan 1.5T MR line is enhanced with a new exterior, including new covers and lighting around the bore, Toshiba said in a press release. The Titan 8-channel supports a variety of clinical applications, with features such as a 71 cm bore, Toshiba’s Pianissimo noise-reduction technology, non-contrast imaging, integrated coils with Octave Speeder technology and the M-Power user interface.

For providers that require enhanced cardiac imaging, the Titan line is upgradeable to a 16- or 32-channel system, according to the Tustin, Calif.-based company.



Around the web

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

One product is being pulled from the market, and the other is receiving updated instructions for use.

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?